Literature DB >> 7906508

von Willebrand factor antigen compared with other factors in vasculitic syndromes.

E Ateş1, A Bakkaloğlu, U Saatçi, O Söylemezoğlu.   

Abstract

In order to analyse their role as a specific marker of vascular damage and their value in monitoring disease activity the plasma concentrations of von Willebrand factor antigen (vWFAg) and the ristocetin cofactor (RiCoF) activities were determined in 43 children with vasculitis and 20 controls. These patients were sub-divided into three groups according to diagnosis: Henoch-Schönlein purpura (n = 18), polyarteritis nodosa (n = 16), and systemic lupus erythematosus (n = 9). High concentrations of vWFAg and activities of RiCoF were found in all the patient groups. vWFAg and RiCoF returned to normal as the patients became symptom free and remained above normal in those with continuing symptoms. The amount of vWFAg did not correlate with the acute phase reactants. vWFAg acted as a specific marker of vascular damage and was useful for the monitoring of disease activity both in small vessel vasculitis and systemic necrotising arteritis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7906508      PMCID: PMC1029680          DOI: 10.1136/adc.70.1.40

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  18 in total

1.  Standard nomenclature for factor VIII and von Willebrand factor: a recommendation by the International Committee on Thrombosis and Haemostasis.

Authors:  V J Marder; P M Mannucci; B G Firkin; L W Hoyer; D Meyer
Journal:  Thromb Haemost       Date:  1985-12-17       Impact factor: 5.249

2.  Enzyme immunoassay for factor VIII-related antigen.

Authors:  J Cejka
Journal:  Clin Chem       Date:  1982-06       Impact factor: 8.327

3.  Abnormalities of factor VIII related protein multimers in the haemolytic uraemic syndrome.

Authors:  P E Rose; S M Enayat; R Sunderland; P E Short; C E Williams; F G Hill
Journal:  Arch Dis Child       Date:  1984-12       Impact factor: 3.791

4.  The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura.

Authors:  J A Mills; B A Michel; D A Bloch; L H Calabrese; G G Hunder; W P Arend; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

5.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

6.  Increased von Willebrand factor antigen in the plasma of patients with vasculitis.

Authors:  S R Nusinow; A B Federici; T S Zimmerman; J G Curd
Journal:  Arthritis Rheum       Date:  1984-12

7.  Synthesis of von Willebrand factor by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

8.  Elevation of von Willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis.

Authors:  A B Federici; R I Fox; L R Espinoza; T S Zimmerman
Journal:  Arthritis Rheum       Date:  1984-09

9.  Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon.

Authors:  M B Kahaleh; I Osborn; E C LeRoy
Journal:  Ann Intern Med       Date:  1981-04       Impact factor: 25.391

10.  Biosynthesis of von Willebrand protein by human megakaryocytes.

Authors:  L A Sporn; S I Chavin; V J Marder; D D Wagner
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

View more
  6 in total

Review 1.  Henoch-Schönlein purpura.

Authors:  E J Tizard
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

2.  Circulating adhesion molecules ICAM-1, E-selectin, and von Willebrand factor in Henoch-Schönlein purpura.

Authors:  O Söylemezoglu; N Sultan; T Gursel; N Buyan; E Hasanoglu
Journal:  Arch Dis Child       Date:  1996-12       Impact factor: 3.791

3.  Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease.

Authors:  M C Nash; V Shah; M J Dillon
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

4.  Henoch-Schonlein purpura with high factor VIII levels and deep venous thrombosis: an association or coincidence?

Authors:  Rezan Topaloglu; Umut Selda Bayrakci; Barbaros Cil; Diclehan Orhon; Aysin Bakkaloglu
Journal:  Rheumatol Int       Date:  2008-02-19       Impact factor: 2.631

5.  Laboratory markers indicating gastrointestinal involvement of henoch-schönlein purpura in children.

Authors:  Jeana Hong; Hye Ran Yang
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2015-03-30

Review 6.  Clinical Perspective on Primary Angiitis of the Central Nervous System in Childhood (cPACNS).

Authors:  Martin Smitka; Normi Bruck; Kay Engellandt; Gabriele Hahn; Ralf Knoefler; Maja von der Hagen
Journal:  Front Pediatr       Date:  2020-07-03       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.